(Q54702771)

3 June 2018

title

BRAF mutation status in gastrointestinal stromal tumors. (English)

1 reference

3 June 2018

author name string

Isabelle Hostein

1

1 reference

3 June 2018

Nicolas Faur

2

1 reference

3 June 2018

Charlotte Primois

3

1 reference

3 June 2018

Frédérique Boury

4

1 reference

3 June 2018

Jérome Denard

5

1 reference

3 June 2018

Jean-François Emile

6

1 reference

3 June 2018

Pierre-Paul Bringuier

7

1 reference

3 June 2018

Jean-Yves Scoazec

8

1 reference

3 June 2018

Jean-Michel Coindre

9

1 reference

3 June 2018

American Journal of Clinical Pathology

language of work or name

English

1 reference

inferred from

publication date

1 January 2010

1 reference

3 June 2018

American Journal of Clinical Pathology

published in

1 reference

3 June 2018

volume

133

1 reference

3 June 2018

issue

1

1 reference

3 June 2018

page(s)

141-148

1 reference

3 June 2018

PDGFRA activating mutations in gastrointestinal stromal tumors.

cites work

1 reference

https://api.crossref.org/works/10.1309%2FAJCPPCKGA2QGBJ1R

Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPPCKGA2QGBJ1R

Signal transduction by several KIT juxtamembrane domain mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPPCKGA2QGBJ1R

Raf kinases: oncogenesis and drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPPCKGA2QGBJ1R

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPPCKGA2QGBJ1R

Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPPCKGA2QGBJ1R

Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPPCKGA2QGBJ1R

Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPPCKGA2QGBJ1R

Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPPCKGA2QGBJ1R

Rapid screening of 4000 individuals for germ-line variations in the BRAF gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPPCKGA2QGBJ1R

Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPPCKGA2QGBJ1R

Somatic activation of KIT in distinct subtypes of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPPCKGA2QGBJ1R

Gene expression profiling of papillary thyroid carcinoma identifies transcripts correlated with BRAF mutational status and lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPPCKGA2QGBJ1R

BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPPCKGA2QGBJ1R

Confirmation of a BRAF mutation-associated gene expression signature in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPPCKGA2QGBJ1R

Phospho-ERK staining is a poor indicator of the mutational status of BRAF and NRAS in human melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPPCKGA2QGBJ1R

Lack of association between BRAF V600E mutation and mitogen-activated protein kinase activation in papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPPCKGA2QGBJ1R

Gastrointestinal stromal tumors: report of an audit and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPPCKGA2QGBJ1R

Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPPCKGA2QGBJ1R

Kinase inhibition with BAY 43-9006 in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPPCKGA2QGBJ1R

Molecular Analysis of c-KitandPDGFRAin GISTs Diagnosed by EUS

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPPCKGA2QGBJ1R

Enhanced B-Raf protein expression is independent of V600E mutant status in thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPPCKGA2QGBJ1R

21 January 2018

Identifiers

DOI

10.1309/AJCPPCKGA2QGBJ1R

1 reference

3 June 2018

PubMed ID

20023270

1 reference

3 June 2018